Evidence map›Paper›PMID 41893938›Full record

ArticleEsophagus : official journal of the Japan Esophageal Society2026

How I do it: The Hi-UP approach-single-port da Vinci SP-assisted mediastinoscopic subtotal esophagectomy with a transhiatal-dominant strategy in the abdominal and cervical phases.

Takeshi Omori, Tomoki Makino, Yujiro Nakahara, Kohei Murakami, Tadafumi Asaoka, Hidekazu Takahashi, Tomofumi Ohashi, Kazuya Iwamoto, Masakatsu Paku, Syohei Takaichi and 3 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Esophagus : official journal of the Japan Esophageal Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Takeshi OmoriDepartment of Gastrointestinal Surgery, Osaka International Medical and Science Center, Osaka Keisatsu Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka, 543-0042, Japan. taketakebigforest@gmail.com.ORCID http://orcid.org/0000-0001-5495-6516
Tomoki MakinoDepartment of Gastroenterological Surgery, The University of Osaka Graduate School of Medicine/Faculty of Medicine, Osaka, Japan.
Yujiro NakaharaDepartment of Gastrointestinal Surgery, Osaka International Medical and Science Center, Osaka Keisatsu Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka, 543-0042, Japan.
Kohei MurakamiDepartment of Gastrointestinal Surgery, Osaka International Medical and Science Center, Osaka Keisatsu Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka, 543-0042, Japan.
Tadafumi AsaokaDepartment of Gastrointestinal Surgery, Osaka International Medical and Science Center, Osaka Keisatsu Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka, 543-0042, Japan.
Hidekazu TakahashiDepartment of Gastrointestinal Surgery, Osaka International Medical and Science Center, Osaka Keisatsu Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka, 543-0042, Japan.
Tomofumi OhashiDepartment of Gastrointestinal Surgery, Osaka International Medical and Science Center, Osaka Keisatsu Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka, 543-0042, Japan.
Kazuya IwamotoDepartment of Gastrointestinal Surgery, Osaka International Medical and Science Center, Osaka Keisatsu Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka, 543-0042, Japan.
Masakatsu PakuDepartment of Gastrointestinal Surgery, Osaka International Medical and Science Center, Osaka Keisatsu Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka, 543-0042, Japan.
Syohei TakaichiDepartment of Gastrointestinal Surgery, Osaka International Medical and Science Center, Osaka Keisatsu Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka, 543-0042, Japan.
Satoshi IshikawaDepartment of Gastrointestinal Surgery, Osaka International Medical and Science Center, Osaka Keisatsu Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka, 543-0042, Japan.
Yuichiro DokiDepartment of Gastroenterological Surgery, The University of Osaka Graduate School of Medicine/Faculty of Medicine, Osaka, Japan.
Ichiro TakemasaDepartment of Gastrointestinal Surgery, Osaka International Medical and Science Center, Osaka Keisatsu Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka, 543-0042, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mediastinoscopic esophagectomy for thoracic esophageal cancer may reduce pulmonary morbidity; however, upper mediastinal lymphadenectomy, particularly along the left recurrent laryngeal nerve (station 106recL), remains technically challenging. We developed a transhiatal-dominant mediastinoscopic subtotal esophagectomy using the da Vinci SP system for both the abdominal and cervical phases. After completing lower and mid-mediastinal lymphadenectomy while preserving the mediastinal pleura, transhiatal dissection is advanced beyond the carina into the upper mediastinum to perform 106recL lymphadenectomy along the left recurrent laryngeal nerve from its turning point beneath the aortic arch. The cervical phase is limited to confirming and completing the cranial 106recL dissection. Two patients had no postoperative morbidity, and bilateral vocal fold mobility was confirmed by laryngoscopy on postoperative day 3. Transhiatal/cervical console times were 180/71 and 200/45 min, respectively, and postoperative hospital stay was 13 days in both cases. This transhiatal-dominant, dual-phase da Vinci SP approach appears feasible for thoracic esophageal cancer.

Indexed as

Esophageal NeoplasmsEsophagectomyMediastinoscopyRobotic Surgical ProceduresAgedFemaleHumansLymph Node ExcisionMaleMediastinumMiddle AgedNeckRecurrent Laryngeal Nerveda Vinci SPEsophageal cancerEsophagectomyMediastinoscopyRecurrent laryngeal nerve

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.